An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
Kellow, J, Lee, O Y, Chang, F Y, Thongsawat, S, Mazlam, M Z, Yuen, H, Gwee, K A, Bak, Y T, Jones, J, Wagner, A
Published in Gut (01.05.2003)
Published in Gut (01.05.2003)
Get full text
Journal Article